Our findings call for the prioritisation of further trials into the efficacy and safety of doses of primaquine between 0.1 mg/kg and 0.4 mg/kg ( including the dose of 0.25 mg/kg recently recommended by WHO ) , in view of the potential for widespread use of the drug to block malaria transmission .